Patent disputes are rising across the medtech landscape, and smart companies are preparing before litigation begins. Hear from industry experts who will offer practical guidance to help medtech leaders protect innovation, manage risk, and strengthen their competitive position.
Attendees will learn:
• The latest trends in patent litigation
• How the evolving USPTO patent policies impact medtech litigation
• Key steps to manage risk, reduce exposure and safeguard intellectual property
• Best practices for financing and preparing for high-stakes disputes
Speakers
• Matthew Levinstein, IP litigator & shareholder in Greenberg Traurig’s Intellectual Property Litigation Group in the firm’s Chicago office
• David Magee, IP litigator & shareholder in Greenberg Traurig’s Intellectual Property Litigation Group in the firm’s Boston office
• David Dykeman, co-chair of Greenberg Traurig's global Life Sciences & Medical Technology Group & MassMEDIC Board Member